These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8669830)

  • 1. Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.
    Mouchard-Delmas C; Gourdier B; Vistelle R; Wiczewski M
    Anticancer Res; 1995; 15(6B):2593-6. PubMed ID: 8669830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
    Spigelman MK; Zappulla RA; Strauchen JA; Feuer EJ; Johnson J; Goldsmith SJ; Malis LI; Holland JF
    Cancer Res; 1986 Mar; 46(3):1453-7. PubMed ID: 3510725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the blood-brain barrier permeability by vinorelbine: effect of intracarotid infusion compared with intravenous infusion.
    Mouchard-Delmas C; Gourdier B; Vistelle R; Wiczewski M
    Anticancer Drugs; 1996 Feb; 7(2):213-9. PubMed ID: 8740728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
    Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
    Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
    Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
    Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
    Preston E; Slinn J; Vinokourov I; Stanimirovic D
    J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis.
    Kozler P; Pokorný J
    Sb Lek; 2003; 104(3):255-62. PubMed ID: 15224531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
    Brown RC; Egleton RD; Davis TP
    Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WR-2721 entry into the brain across a modified blood-brain barrier.
    Lamperti A; Conger AD; Jenkins O; Cohen G; Rizzo A; Davis ME; Sodicoff M
    Radiat Res; 1988 Aug; 115(2):303-13. PubMed ID: 2841714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier integrity in a rat model of emergency preservation and resuscitation.
    Lahoud-Rahme MS; Stezoski J; Kochanek PM; Melick J; Tisherman SA; Drabek T
    Resuscitation; 2009 Apr; 80(4):484-8. PubMed ID: 19203824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats.
    Baba T; Black KL; Ikezaki K; Chen KN; Becker DP
    J Cereb Blood Flow Metab; 1991 Jul; 11(4):638-43. PubMed ID: 1675639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of indomethacin (a prostaglandin synthetase inhibitor) on the permeability of blood-brain and blood-CSF barriers in rat.
    Dey PK; Sharma HS; Rao KS
    Indian J Physiol Pharmacol; 1980; 24(1):25-36. PubMed ID: 7364458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats.
    Pan GY; Liu XD; Liu GQ
    Acta Pharmacol Sin; 2000 Jul; 21(7):613-6. PubMed ID: 11360668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
    Erdlenbruch B; Schinkhof C; Kugler W; Heinemann DE; Herms J; Eibl H; Lakomek M
    Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of papaverine-mediated blood-brain barrier disruption in rats.
    Bhattacharjee AK; Kondoh T; Nagashima T; Ikeda M; Ehara K; Tamaki N
    Biochem Biophys Res Commun; 2001 Nov; 289(2):548-52. PubMed ID: 11716508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents.
    Spigelman MK; Zappulla RA; Johnson J; Goldsmith SJ; Malis LI; Holland JF
    J Neurosurg; 1984 Oct; 61(4):674-8. PubMed ID: 6470777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier disruption in the treatment of brain tumors.
    Blanchette M; Fortin D
    Methods Mol Biol; 2011; 686():447-63. PubMed ID: 21082387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of blood-brain barrier (BBB) in rat by immobilization stress: role of serotonin (5-HT).
    Sharma HS; Dey PK
    Indian J Physiol Pharmacol; 1981; 25(2):111-22. PubMed ID: 7287133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized changes in blood-brain barrier permeability following the administration of antineoplastic drugs.
    MacDonell LA; Potter PE; Leslie RA
    Cancer Res; 1978 Sep; 38(9):2930-4. PubMed ID: 679202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intracarotid etoposide on opening the blood-brain barrier.
    Spigelman MK; Zappulla RA; Goldberg JD; Goldsmith SJ; Marotta D; Malis LI; Holland JF
    Cancer Drug Deliv; 1984; 1(3):207-11. PubMed ID: 6399858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.